Loading company…
MedaSystems connects patients, pharmaceutical companies, and providers for expanded access requests.
MedaSystems develops a platform for patients who cannot participate in clinical trials to request investigational therapies, and for pharmaceutical manufacturers and healthcare providers to coordinate requests. Founded in 2020, the company is based in California. In March 2025, it raised an undisclosed seed amount from returning investors Debiopharm Innovation Fund and Nina Capital, along with an individual investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in